Toxicity testing in the 21st century beyond environmental chemicals

Cite This

Files in this item

Checksum: MD5:72d95f92e2a8540ef22c4bbf944b5b6d

ROVIDA, Costanza, Shoji ASAKURA, Mardas DANESHIAN, Hana HOFMAN-HUETHER, Marcel LEIST, Leo MEUNIER, David REIF, Anna ROSSI, Markus SCHMUTZ, Jean-Pierre VALENTIN, Joanne ZURLO, Thomas HARTUNG, 2015. Toxicity testing in the 21st century beyond environmental chemicals. In: Alternatives to Animal Experimentation : ALTEX. 32(3), pp. 171-181. ISSN 1868-596X. eISSN 1868-8551. Available under: doi: 10.14573/altex.1506201

@article{Rovida2015Toxic-33112, title={Toxicity testing in the 21st century beyond environmental chemicals}, year={2015}, doi={10.14573/altex.1506201}, number={3}, volume={32}, issn={1868-596X}, journal={Alternatives to Animal Experimentation : ALTEX}, pages={171--181}, author={Rovida, Costanza and Asakura, Shoji and Daneshian, Mardas and Hofman-Huether, Hana and Leist, Marcel and Meunier, Leo and Reif, David and Rossi, Anna and Schmutz, Markus and Valentin, Jean-Pierre and Zurlo, Joanne and Hartung, Thomas} }

<rdf:RDF xmlns:dcterms="" xmlns:dc="" xmlns:rdf="" xmlns:bibo="" xmlns:dspace="" xmlns:foaf="" xmlns:void="" xmlns:xsd="" > <rdf:Description rdf:about=""> <dcterms:abstract xml:lang="eng">After the publication of the report titled Toxicity Testing in the 21st Century – A Vision and a Strategy, many initiatives started to foster a major paradigm shift for toxicity testing – from apical endpoints in animal-based tests to mechanistic endpoints through delineation of pathways of toxicity (PoT) in human cell based systems. The US EPA has funded an important project to develop new high throughput technologies based on human cell based in vitro technologies. These methods are currently being incorporated into the chemical risk assessment process. In the pharmaceutical industry, the efficacy and toxicity of new drugs are evaluated during preclinical investigations that include drug metabolism, pharmacokinetics, pharmacodynamics and safety toxicology studies. The results of these studies are analyzed and extrapolated to predict efficacy and potential adverse effects in humans. However, due to the high failure rate of drugs during the clinical phases, a new approach for a more predictive assessment of drugs both in terms of efficacy and adverse effects is getting urgent. The food industry faces the challenge of assessing novel foods and food ingredients for the general population, while using animal safety testing for extrapolation purposes is often of limited relevance. The question is whether the latest paradigm shift proposed by the Tox21c report for chemicals may provide a useful tool to improve the risk assessment approach also for drugs and food ingredients.</dcterms:abstract> <dc:contributor>Reif, David</dc:contributor> <dcterms:title>Toxicity testing in the 21st century beyond environmental chemicals</dcterms:title> <dc:contributor>Schmutz, Markus</dc:contributor> <dc:contributor>Leist, Marcel</dc:contributor> <dc:creator>Leist, Marcel</dc:creator> <dc:creator>Daneshian, Mardas</dc:creator> <dc:creator>Hartung, Thomas</dc:creator> <dc:contributor>Meunier, Leo</dc:contributor> <dc:contributor>Zurlo, Joanne</dc:contributor> <dspace:isPartOfCollection rdf:resource=""/> <dc:creator>Hofman-Huether, Hana</dc:creator> <dc:contributor>Asakura, Shoji</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:contributor>Hofman-Huether, Hana</dc:contributor> <dc:contributor>Daneshian, Mardas</dc:contributor> <dc:creator>Reif, David</dc:creator> <dc:date rdf:datatype="">2016-02-24T15:00:31Z</dc:date> <dcterms:rights rdf:resource=""/> <dcterms:hasPart rdf:resource=""/> <dc:contributor>Valentin, Jean-Pierre</dc:contributor> <dc:creator>Zurlo, Joanne</dc:creator> <dc:contributor>Rovida, Costanza</dc:contributor> <dc:contributor>Rossi, Anna</dc:contributor> <dcterms:isPartOf rdf:resource=""/> <dc:contributor>Hartung, Thomas</dc:contributor> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dc:creator>Asakura, Shoji</dc:creator> <dspace:hasBitstream rdf:resource=""/> <dc:creator>Rossi, Anna</dc:creator> <dc:creator>Valentin, Jean-Pierre</dc:creator> <dc:creator>Schmutz, Markus</dc:creator> <dc:language>eng</dc:language> <dc:creator>Meunier, Leo</dc:creator> <dc:creator>Rovida, Costanza</dc:creator> <dcterms:available rdf:datatype="">2016-02-24T15:00:31Z</dcterms:available> <dc:rights>Attribution 4.0 International</dc:rights> <dcterms:issued>2015</dcterms:issued> <bibo:uri rdf:resource=""/> </rdf:Description> </rdf:RDF>

Downloads since Feb 24, 2016 (Information about access statistics)

Rovida_0-302232.pdf 485

This item appears in the following Collection(s)

Attribution 4.0 International Except where otherwise noted, this item's license is described as Attribution 4.0 International

Search KOPS


My Account